TGRX-678 - Shenzhen TargetRx
Iclusig (ponatinib) - Takeda
Nailike (olverembatinib) - Takeda
Scemblix (asciminib) - Novartis
TERN-701 - Terns Pharma
https://meetings-api.hematology.org/api/abstract/vmpreview/297329
 
Qian Jiang1; Weiming Li2; Yanli Zhang3; Qiang WANG4; Suning Chen5; Bingcheng LIU6; Jie Jin7; Zhenfang Liu8; Zhuogang Liu9; Jianyu Weng10; Xin Du11; Xielan Zhao12; Li Meng13; Shujie Yan14; xiaomeng Dong14; Yihan Wang14; Jingrong Cao14
 
Nov 4, 2025
 
Next